MIRM vs MLYS Stock Comparison
MIRM currently leads MLYS in this stock comparison, with AIQ scores of 53 vs 33. The clearest difference is momentum.
What is the main difference between MIRM and MLYS?
MIRM leads the current stock comparison as Mirum Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Mirum Pharmaceuticals, Inc. vs Mineralys Therapeutics, Inc.
MIRM leads
MIRM leads by 20 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 6 points over 30 sessions. Wall Street currently favors MLYS on target upside.
Competitive: 3 of 5 evidence groups support MIRM, its lead is widening, and its current signal state is conflicted.
Mirum Pharmaceuticals, Inc.
Mineralys Therapeutics, Inc.
The Algovestiq AIQ Score currently favors MIRM over MLYS, 53 versus 33 as of Nov 15, 2026. MIRM's advantage is driven primarily by stronger momentum and risk resilience. MIRM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors MLYS. 3 of 5 covered evidence groups favor MIRM today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. MIRM lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions.
Compare Mirum Pharmaceuticals, Inc. and Mineralys Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare MIRM and MLYS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum54 vs 23MIRM +31
- Risk Resilience51 vs 35MIRM +16
- Quality52 vs 44MIRM +8
3 of 5 evidence groups favor MIRM. MIRM’s edge is concentrated in momentum and risk resilience.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
MIRM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — MIRM and MLYS both carry a full feed there.
The central trade-off
MIRM (Mirum Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
MLYS (Mineralys Therapeutics, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 92.5% against 50.6%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
MIRMMIRM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
MLYSMLYS on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
MIRMMIRM on the Momentum factor, by 31 points.
Lower downside
MIRMMIRM on Risk Resilience, by 16 points.
Analyst upside
MLYSMLYS on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors MIRM, analyst targets favor MLYS. That disagreement is the most useful thing on this page.
| Measure | MIRM | MLYS | Note |
|---|---|---|---|
| Implied upside to target | +66.9% | +89.2% | MLYS has more room |
| Target dispersion | +45.9% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 14 | 11 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor MIRM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | MIRM | 53 vs 33 |
| Fundamentals | Even | EPS growth 41.5% vs 77.5%; TTM ROE 75.2% vs -11.4% |
| Valuation | Not covered | Not covered |
| Technicals | MIRM | Price vs 50-day 5.9% vs -32.3%; vs 200-day -4.5% vs -41.4% |
| Risk Resilience | MIRM | Risk Resilience 51 vs 35 |
| Analyst expectations | MLYS | Target upside 66.9% vs 89.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of MIRM and MLYS and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 20 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MIRM.
How the comparison changed
120 daily snapshots · May 27 – Nov 13MIRM lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions.
- Today
- MIRM +20
- 53 vs 33
- 7 sessions ago
- MIRM +17
- 50 vs 33
- 30 sessions ago
- MIRM +6
- 47 vs 41
- 90 sessions ago
- MIRM +8
- 53 vs 45
The lead changed hands once in this window, most recently on Sep 15 when MLYS moved ahead of MIRM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only MIRM
- Low Volume Rally Warning — bearish, volume, short horizon (0.54x)
- TRIX Bullish Signal — bullish, momentum, short horizon
0 bullish / 5 bearish / 1 neutral
Only MLYS
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- Downtrend Structure Active — bearish, trend, long horizon
- Keltner Channel Breakdown — bearish, volatility, short horizon
Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.
MIRM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +0.71%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.1%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1MLYS closes the Momentum gap — currently 31 points behind, the largest single contributor to MIRM's edge.
- 2MLYS's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3MIRM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | MIRM | MLYS |
|---|---|---|
| Revenue growth (YoY) | 5.4% | 0% |
| EPS growth (YoY) | 41.5% | 77.5% |
| Gross margin | 81.7% | 0% |
| Operating margin | -25.3% | 0% |
| Return on equity (TTM) | 75.2% | -11.4% |
| Debt to equity | -13.72 | 0.2 |
Performance
MIRM leads 6 of 6 windows| Metric | MIRM | MLYS |
|---|---|---|
| 1 week (5 sessions) | 0.3% | 0% |
| 1 month (20 sessions) | 17.3% | -24.5% |
| 3 months (63 sessions) | -5.8% | -41.2% |
| 6 months (126 sessions) | -8% | -44% |
| Year to date | 19% | -57.8% |
| 1 year (252 sessions) | 32.8% | -67.6% |
Technicals
MIRM has the stronger structure| Metric | MIRM | MLYS |
|---|---|---|
| RSI (14) | 59.9 | 32 |
| ADX (14) | 26.1 | 26.3 |
| Price vs 50-day | 5.9% | -32.3% |
| Price vs 200-day | -4.5% | -41.4% |
| Volatility (1M, annualized) | 50.6% | 92.5% |
Risk
MIRM is the more resilient| Metric | MIRM | MLYS |
|---|---|---|
| Beta | 1.07 | 1.54 |
| Sharpe ratio | 0.79 | -1.48 |
| Sortino ratio | 1.12 | -2.01 |
| Max drawdown | -38.4% | -65.6% |
| Current drawdown | -26.9% | -65.4% |
| Annualized volatility | 48.6% | 61.7% |
| Value at risk (95%) | -4.9% | -6.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, MIRM or MLYS?
On the Algovestiq AIQ Score, MIRM is the stronger of the two as of Nov 15, 2026, scoring 53 against MLYS's 33. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is MIRM or MLYS the better buy right now?
MIRM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor MIRM over MLYS?
The composite weights Quality, Value, Momentum and Risk Resilience. MIRM leads Momentum by 31 points; MIRM leads Risk Resilience by 16 points; MIRM leads Quality by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, MIRM or MLYS?
Analyst price targets imply +66.9% upside for MIRM and +89.2% for MLYS, so the Street currently favors MLYS. That points the opposite way to the AIQ Score, which favors MIRM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, MIRM or MLYS?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, MIRM or MLYS?
MLYS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, MIRM or MLYS?
MIRM on the Momentum factor, by 31 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, MIRM or MLYS?
MIRM is the more resilient of the two, so the other name carries the higher downside risk. MIRM on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is MIRM more profitable than MLYS?
MIRM leads on the comparable margin measures — gross margin 81.7% vs 0%; operating margin -25.3% vs 0%; ttm roe 75.2% vs -11.4%.
Is MIRM's lead over MLYS getting stronger or weaker?
MIRM lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-15, when MLYS moved ahead of MIRM.
What would change the MIRM vs MLYS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: MLYS closes the Momentum gap — currently 31 points behind, the largest single contributor to MIRM's edge; MLYS's Death Cross Active resolves — a bearish trend rule currently active against it; MIRM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about MIRM and MLYS?
MIRM: 1 bullish / 2 bearish / 1 neutral, conflicted. MLYS: 0 bullish / 5 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on MIRM is Death Cross Active (bearish, long horizon). On MLYS it is Death Cross Active (bearish, long horizon).
Compare MIRM and MLYS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.